University of Bologna, Italy
Dr. Alessandra Rossi earned her M.Sc in biology, with specialism in molecular biology, at the Department of Pharmacology at the University of Bologna. There, she performed her PhD thesis at the Department of Human Pathology studying the molecular mechanisms of retinoic acid derivatives in cancer models. After earning her specialization in pharmacology, she worked as a postdoctoral scientist at the University of Siena and Temple University (Philadelphia, PA, USA), where she had the opportunity to apply her research skills in several projects that included the screening and profiling of anti-cancer compounds and the elucidation of new anti-cancer properties of molecules already in the clinic. After having worked for two years in the medical affairs at the pharmaceutical company Eli Lilly, she joined the University Medical Center Eppendorf of Hamburg, where she focused on the development of targeted Next Generation Sequencing approaches for mutational profiling of plasma cell dyscrasias and analysis of liquid biopsy in solid tumors. Currently, she is in the scientific committee of Luigi and Teresa de Beaumont Bonelli Foundation for Cancer Research, is working as a nutritionist for cancer patients and as a researcher at the University of Bologna, where she has been working on the evaluation of potential screening biomarkers for lung cancer.
Molecular Biology, Clinical Oncology, Nutrition